While ReA’s capacity to modulate core signaling pathways like NF-κB and Nrf2 was previously established in non-renal models (Fu et al., 2022; Wang et al., 2022; Xiao et al., 2021), this work provides the first direct link between ReA and the immunopathology of renal disease. The gene discussed is PHB2; the disease is kidney disorder.